Monitoring Stomach Function With an Intragastric Balloon - a Pilot
NCT ID: NCT03500887
Last Updated: 2018-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2015-11-30
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a New Enteral Feeding Tube for the Measurement of Esophageal and Gastric Pressure
NCT01111578
Non-invasive Measurement of Gastric Motility
NCT04992884
Efficacy of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium
NCT02249975
Positioning and Ultrasound Examination of the Gastric Antrum
NCT03205774
Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation
NCT04206111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1. Bag inflated so that intrabagpressure increases with 2 mmHg
intragastric bag
2. Bag inflated to ¾ volume of 1
intragastric bag
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intragastric bag
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and female.
* Patients must provide witnessed written informed consent prior to any study procedures being performed.
Exclusion Criteria
* Have severely decreased kidney function.
* Have severely decreased liver function.
* Have severe heart disease, for example a history of irregular heartbeats, angina or heart attack.
* Have severe lung disease.
* Have severe psychiatric illness or neurological illness.
* Have any gastrointestinal disease.
* Have any dyspeptic symptoms.
* Women that are pregnant or breastfeeding.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof Dr Jan Tack
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Dr Jan Tack
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Tack, Prof.
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZLeuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S58484
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.